Jean-Jacques Bienaimé
Chair of the BoardatKeros Therapeutics· In proxies 2024–2025
Jean-Jacques Bienaimé sits on 3 public boards.
Boards1
- Keros TherapeuticsLead independent director · 0 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Keros TherapeuticsPublic company · 2 yr
- Chair of the Board2024 – Present · 2 yrStock in role -71%
- Immunome, Inc.Public company
- Director? – PresentNo stock prices for these years
- Incyte CorporationPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
Two people shown as one, or a wrong number?